Tandem Diabetes Care (TNDM) Change in Cash (2013 - 2026)
Tandem Diabetes Care's (TNDM) quarterly Change in Cash came in at $88.7 million in Q1 2026, up 666.35% YoY from $11.6 million in Q1 2025, and up 6854.84% on a QoQ basis from -$1.3 million in Q4 2025.
Tandem Diabetes Care (TNDM) Change in Cash (2013 - 2026) Analysis & Trends
Tandem Diabetes Care (TNDM) has 14 years of Change in Cash data on file, last reported at $88.7 million in Q1 2026.
- Quarterly Change in Cash rose 666.35% year-over-year to $88.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $125.8 million (up 2426.57% YoY) and the FY2025 annual result came in at $21.4 million, up 106.44% from the prior year.
- Change in Cash improved to $88.7 million in Q1 2026, from -$1.3 million in the prior quarter.
- In the past five years, Change in Cash ranged from a high of $88.7 million in Q1 2026 to a low of -$51.1 million in Q3 2023.
- A 5-year average of $6.4 million and a median of $3.0 million in 2023 frame the typical range for Change in Cash.
- The widest YoY moves for Change in Cash: up 1974.14% in 2025, down 14208.11% in 2025.
- Tracing TNDM's Change in Cash over 5 years: stood at $48.7 million in 2022, then sank by 142.57% to -$20.7 million in 2023, then soared by 197.36% to $20.2 million in 2024, then plunged by 106.5% to -$1.3 million in 2025, then jumped by 6854.84% to $88.7 million in 2026.
- The last three Change in Cash figures came in at $88.7 million (Q1 2026), -$1.3 million (Q4 2025), and $27.8 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Cash (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | -1.70 Bn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 513.00 Mn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 803.00 Mn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | -890.00 Mn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 462.20 Mn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | -13.20 Mn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | -180.00 Mn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | -1.21 Bn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 42.80 Mn |
| 10 | Tandem Diabetes Care | 1.56 Bn | 1.10 Bn | 144.78 Mn | -116.51 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -116.51 Mn |
| Mar 31, 2026 | 88.69 Mn |
| Dec 31, 2025 | -1.31 Mn |
| Sep 30, 2025 | 27.84 Mn |
| Jun 30, 2025 | 10.54 Mn |
| Mar 31, 2025 | -15.66 Mn |
| Dec 31, 2024 | 20.20 Mn |
| Sep 30, 2024 | 1.34 Mn |
| Jun 30, 2024 | -11.28 Mn |
| Mar 31, 2024 | 111,000.00 |
| Dec 31, 2023 | -20.74 Mn |
| Sep 30, 2023 | -51.14 Mn |
| Jun 30, 2023 | 2.99 Mn |
| Mar 31, 2023 | -44.76 Mn |
| Dec 31, 2022 | 48.73 Mn |
| Sep 30, 2022 | 8.82 Mn |
| Jun 30, 2022 | 21.29 Mn |
| Mar 31, 2022 | 22.50 Mn |
| Dec 31, 2021 | -41.19 Mn |
| Sep 30, 2021 | 13.80 Mn |